Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus

B.M. Scirica; D.L. Bhatt; E. Braunwald; P.G. Steg; J. Davidson; B. Hirshberg; P. Ohman; R. Frederich; S.D. Wiviott; E.B. Hoffman; M.A Cavender; J.A. Udell; N. Desai; O. Mosenzon; D.K. McGuire; K.K. Ray; L.A. Leiter; [No Value] et al.; W. Spiering; I. Raz

Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus

Translated title of the contribution: Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus

B.M. Scirica, D.L. Bhatt, E. Braunwald, P.G. Steg, J. Davidson, B. Hirshberg, P. Ohman, R. Frederich, S.D. Wiviott, E.B. Hoffman, M.A Cavender, J.A. Udell, N. Desai, O. Mosenzon, D.K. McGuire, K.K. Ray, L.A. Leiter, [No Value] et al., W. Spiering, I. Raz

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus
Original language	Undefined/Unknown
Pages (from-to)	1317-1326
Number of pages	10
Journal	New England Journal of Medicine
Volume	369
Issue number	14
Publication status	Published - 2013

Access to Document

http://www.ncbi.nlm.nih.gov/pubmed/23992601

Cite this

Scirica, B. M., Bhatt, D. L., Braunwald, E., Steg, P. G., Davidson, J., Hirshberg, B., Ohman, P., Frederich, R., Wiviott, S. D., Hoffman, E. B., Cavender, M. A., Udell, J. A., Desai, N., Mosenzon, O., McGuire, D. K., Ray, K. K., Leiter, L. A., et al., N. V., Spiering, W., & Raz, I. (2013). Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus. New England Journal of Medicine, 369(14), 1317-1326. http://www.ncbi.nlm.nih.gov/pubmed/23992601

@article{385a2b6eeee54c6ca68c721b3271d253,

title = "Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus",

author = "B.M. Scirica and D.L. Bhatt and E. Braunwald and P.G. Steg and J. Davidson and B. Hirshberg and P. Ohman and R. Frederich and S.D. Wiviott and E.B. Hoffman and M.A Cavender and J.A. Udell and N. Desai and O. Mosenzon and D.K. McGuire and K.K. Ray and L.A. Leiter and {et al.}, {[No Value]} and W. Spiering and I. Raz",

year = "2013",

language = "Undefined/Unknown",

volume = "369",

pages = "1317--1326",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "14",

}

Scirica, BM, Bhatt, DL, Braunwald, E, Steg, PG, Davidson, J, Hirshberg, B, Ohman, P, Frederich, R, Wiviott, SD, Hoffman, EB, Cavender, MA, Udell, JA, Desai, N, Mosenzon, O, McGuire, DK, Ray, KK, Leiter, LA, et al., NV, Spiering, W & Raz, I 2013, 'Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus', New England Journal of Medicine, vol. 369, no. 14, pp. 1317-1326. <http://www.ncbi.nlm.nih.gov/pubmed/23992601>

TY - JOUR

T1 - Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus

AU - Scirica, B.M.

AU - Bhatt, D.L.

AU - Braunwald, E.

AU - Steg, P.G.

AU - Davidson, J.

AU - Hirshberg, B.

AU - Ohman, P.

AU - Frederich, R.

AU - Wiviott, S.D.

AU - Hoffman, E.B.

AU - Cavender, M.A

AU - Udell, J.A.

AU - Desai, N.

AU - Mosenzon, O.

AU - McGuire, D.K.

AU - Ray, K.K.

AU - Leiter, L.A.

AU - et al., [No Value]

AU - Spiering, W.

AU - Raz, I.

PY - 2013

Y1 - 2013

M3 - Article

SN - 0028-4793

VL - 369

SP - 1317

EP - 1326

JO - New England Journal of Medicine

JF - New England Journal of Medicine

IS - 14

ER -